Neeraj Agarwal, Postdoctoral fellow at City of Hope, shared a post on X:
“Stellar presentation at ASCO 2025 by trailblazer Rana McKay on ETCTN trial with radium +|- olaparib in mCRPC prostate cancer rPFS with the combo with/without HRRm.
Data continues to reinforce role of PARPi in rationale combinations,
Toni Choueiri – mentor.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
